Purchase Order 75D30120P07421
Award Date
2/21/20
Potential Completion Date
3/10/20
Potential Value
$127K
Federal Agency
CDC Pittsburgh
Awardee
Biosearch Technologies, Inc.
Ultimate Awardee
Not listed
NAICS Category
325199 - All Other Basic Organic Chemical Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Petaluma, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division. The $787,500.00 contract, which has no set-aside designation, is for the provision of oligonucleotide-based laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides. These products support the CDC's disease surveillance, diagnostic testing, public health research,...
This is a federal contract award to Biosearch Technologies, Inc. LGC Biosearch Technologies Division, a privately-held company that specializes in the design, development, and manufacture of oligonucleotide-based tools. The contract, awarded by the Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services, is an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a potential value of $145,400.00. It is a firm fixed price contract with no...
This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for the delivery of primer probes. The contract is a Blanket Purchase Agreement (BPA) call valued at $626,838.00, with an ultimate completion date of July 30, 2022. Biosearch Technologies, through its LGC Biosearch Technologies division, is a privately held company that specializes in the design, development, and manufacture of oligonucleotide-based tools. This...
The Centers for Disease Control and Prevention (CDC) awarded a $1,343,205.50 firm fixed-price contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division to provide primer probes. This award was not set aside for any specific business type. Biosearch Technologies has a history of providing laboratory supplies like assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts for federal...
This is a firm fixed price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $98,400.00. The contract, which has no set-aside designation, is for the provision of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens like influenza, COVID-19, Ebola, and Brucella....
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $164,625.00. The contract is for the delivery of laboratory kits, with no set-aside designation. Biosearch Technologies, through its LGC Biosearch Technologies division, has provided a variety of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC's public health research and...
The U.S. Centers for Disease Control and Prevention (CDC) has awarded a Definitive Contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division to provide GMP manufacturing of CDC FluSC2 Multiplex EUA and IVD Kits. The $763,453.00 firm fixed-price contract has an ultimate completion date of September 29, 2025. Biosearch Technologies, a privately held manufacturer of oligonucleotide-based tools, will deliver these products to support the CDC's disease surveillance, diagnostic...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc., a privately held company specializing in oligonucleotide-based tools. The contract, valued at $87,500.00, is for the provision of laboratory equipment. Biosearch Technologies has a history of providing laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC, Department of Defense, and National...
This is a $151,050.00 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. The contract is for the provision of laboratory supplies including Biosearch PCR kits for Ebola, Rickettsia, and Variola viruses. This contract does not have a set-aside designation. Biosearch Technologies, a privately held manufacturer of oligonucleotide-based tools, has previously held federal contracts...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Human Services (HHS), to Biosearch Technologies, Inc. (dba Biosearch Technologies). The $473,206.40 contract is for the provision of a SARS-COV-2 Influenza Multiplex Assay, which supports disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens such as COVID-19. Biosearch Technologies,...